[Penile self-injection of a papaverine-phentolamine combination, as treatment of impotence, in patients treated with radical cystoprostatectomy].
Four patients with impotence secondary to radical cystoprostatectomy due to infiltrant vesical urothelial carcinoma, received treatment with a mixture of papaverine-phentolanin, at dosages of 18-0, 34 mg respectively. Good results were obtained in every occasion, all four cases achieving rigid erection for over an hour which allowed penetration. Currently, patients continue peneal self-injection treatment with these drugs, with no complications or therapy failure being reported.
Calahorra Fernández
F J
FJ
Servicio de urología, Hospital 12 de Octubre, Madrid.
Rodríguez
A
A
Castro
M
M
Tamayo
J C
JC
Alvarez
E
E
Leiva
O
O
D000293:Adolescent; D000328:Adult; D015653:Cystectomy / Q000009:adverse effects; D004359:Drug Therapy, Combination; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000008:administration & dosage / Q000627:therapeutic use*; D010646:Phentolamine / Q000009:adverse effects / Q000627:therapeutic use*; D011468:Prostatectomy / Q000009:adverse effects; D012646:Self Administration
D010208:Papaverine; D010646:Phentolamine
Autoinyección peneana de papaverina fentolamina, como tratamiento de la impotencia, en pacientes sometidos a cistoprostatectomía radical.